Skip to Content


In some countries, this medicine may only be approved for veterinary use.

In the US, Levocarnitine (levocarnitine systemic) is a member of the drug class nutraceutical products and is used to treat Carnitine Deficiency and Peripheral Neuropathy.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Treatment of metabolic disease

Chemical Names

(-)-β-hydroxy-gamma-trimetylaminobutyric acid

(3R)-3-Hydroxy-4-(trimetylammonio)butanoate (Ph. Eur.)

(L-3-carboxy-2-hydroxypropyl)trimetylamonium hydroxide, inner salt (WHO)

(R)-3-Carboxy-2-hydroxy-N,N,N-trimetyl-1-propanaminium, inner salt (USP)

(R)-3-Hydroxy-4-trimetylammoniobutyrate (BAN)

1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimetyl-, hydroxide, inner salt, (R)- (USAN)

Foreign Names

  • Levocarnitinum (Latin)
  • Levocarnitin (German)
  • Lévocarnitine (French)
  • Levocarnitina (Spanish)

Generic Names

Brand Names

International Drug Name Search


BANBritish Approved Name
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Ph. Eur.European Pharmacopoeia
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
USPPharmacopoeia of the United States
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.